0001420800-20-000020.txt : 20200806 0001420800-20-000020.hdr.sgml : 20200806 20200806061744 ACCESSION NUMBER: 0001420800-20-000020 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200806 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200806 DATE AS OF CHANGE: 20200806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Colfax CORP CENTRAL INDEX KEY: 0001420800 STANDARD INDUSTRIAL CLASSIFICATION: PUMPS & PUMPING EQUIPMENT [3561] IRS NUMBER: 541887631 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34045 FILM NUMBER: 201079659 BUSINESS ADDRESS: STREET 1: 420 NATIONAL BUSINESS PARKWAY STREET 2: 5TH FLOOR CITY: ANNAPOLIS JUNCTION STATE: MD ZIP: 20701 BUSINESS PHONE: (301) 323-9000 MAIL ADDRESS: STREET 1: 420 NATIONAL BUSINESS PARKWAY STREET 2: 5TH FLOOR CITY: ANNAPOLIS JUNCTION STATE: MD ZIP: 20701 8-K 1 cfx8-kxq22020earnings.htm 8-K Document
false0001420800Colfax CORP 0001420800 us-gaap:CommonStockMember 2020-08-06 2020-08-06 0001420800 cfx:TangibleEquityUnitMember 2020-08-06 2020-08-06 0001420800 2020-08-06 2020-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 6, 2020
 
Colfax Corporation
(Exact name of registrant as specified in its charter)
 
Delaware
001-34045
54-1887631
(State or other jurisdiction
(Commission
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)

 420 National Business Parkway, 5th Floor
Annapolis Junction, MD 20701
(Address of Principal Executive Offices) (Zip Code)
 
(301) 323-9000
(Registrant's telephone number, including area code)

 Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
CFX
New York Stock Exchange
5.75% Tangible Equity Units
CFXA
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02. Results of Operations and Financial Condition.

On August 6, 2020, the Company issued a press release reporting financial results for the second quarter ended July 3, 2020. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into Item 2.02 of this report by reference. The Company has scheduled a conference call for 8:00 a.m. Eastern on August 6, 2020 to discuss its financial results.





Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits


104 Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
August 6, 2020
 
 
 Colfax Corporation
 
 
 
By:
/s/ Douglas J. Pitts
 
 
 
Name:
Douglas J. Pitts
 
 
 
Title:
Vice President
 
 
 
 
Controller and Chief Accounting Officer
 
 
 
 
(Principal Accounting Officer)
 
                                                                                                          

 EX-99.1 2 q22020earningspressrel.htm EXHIBIT 99.1 Exhibit
colfaxlogoa05.jpg
Colfax Reports Second Quarter 2020 Results

•
Achieved objectives to address COVID-19 impacts, including generating positive cash flow
•
Reported $(0.03) EPS from continuing operations and achieved $0.09 of adjusted EPS
•
Sequentially improved sales rates each month during the quarter
•
Continued investments in innovation support long-term growth plans

ANNAPOLIS JUNCTION, MD, August 6, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the second quarter of 2020.

The Company reported a net loss from continuing operations of $3.6 million, or $0.03 per share, in the quarter, compared to net income of $0.01 in the prior year quarter. On an adjusted basis, the Company reported earnings of $0.09 per diluted share, compared to $0.54 in the second quarter of 2019. Adjustments to reported earnings are included in the reconciliation schedules provided.

For the second quarter, Colfax reported net sales of $620 million, 32% lower than the previous year’s quarter due to the current year impact from COVID-19-related demand reductions. Excluding the impact from currency translation adjustments, organic sales decreased 28%. The Company realized sequential improvements for each month in the second quarter, with June organic sales 19% lower than the prior year. The Company also reported second quarter adjusted EBITA of $45 million, or 7.3% of sales, as temporary savings measures partially mitigated the impact from the volume declines.

During the second quarter the Company generated operating cash flow of $37 million and free cash flow of $18 million, and repaid $300 million of its credit agreement borrowings. The Company completed the second quarter with 4.2 times net leverage and ample liquidity, including $66 million of cash and $1.2 billion of capacity under its credit agreement and other facilities.

“During the quarter we stayed focused on our principal objectives of keeping associates safe, maintaining supply to our customers, and protecting Colfax’s financial health,” said Matt Trerotola, Colfax President and CEO. “I’m very pleased with the resiliency of our businesses and teams through this challenging period. We deployed temporary measures and successfully drove Q2 decremental margin to 28%. Sales per day rates sequentially improved each month, including July. We expect to pace our temporary cost measures with sales levels in the third quarter to deliver sequentially higher profit and remain cash flow positive.

“We continue to pursue our growth agenda in this softer demand environment. During the first half of 2020, we launched over 35 new products in our FabTech business, including the WeldCloud Notes document management software to enhance our digital solution tools. Our MedTech business product launches include today’s announcement of Motion iQ™, a patient relationship management tool that seamlessly connects clinicians and patients across the orthopedic care continuum. We are well-positioned to resume our long-term growth momentum as market conditions improve.”

The Company also reported that its Medical Technology segment sales decreased 35% in the quarter on a reported basis and 34% organically versus the prior year period. Fabrication Technology segment sales decreased 30% in the quarter on a reported basis and 25% organically versus the prior year period. Both segments recorded sequential improvements each month during the quarter, with June Medical Technology organic sales declining 16% and Fabrication Technology organic sales declining 20%. The Medical Technology segment reported adjusted EBITA margins of 3.2%, versus 16.5% in the comparable prior year period, and the Fabrication Technology segment reported adjusted EBITA margins of 12.6%, compared to 15.2% in the prior year second quarter.

Given the uncertainties of customer demand due to the COVID-19 pandemic, Colfax is not providing financial guidance for 2020.

Conference Call and Webcast

The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern today, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 6196870 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section. Access to a


supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.

About Colfax Corporation

Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates. Colfax’s common stock is traded on the NYSE under the ticker “CFX.”

Non-GAAP Financial Measures and Other Adjustments

Colfax has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”). These non-GAAP financial measures are adjusted net income from continuing operations, adjusted net income margin from continuing operations, adjusted net income per diluted share from continuing operations, adjusted EBITA (earnings before interest, taxes and amortization), adjusted EBITA margin, organic sales growth, and free cash flow. Colfax also provides adjusted EBITA and adjusted EBITA margin on a segment basis.

Adjusted net income from continuing operations represents net income (loss) from continuing operations excluding restructuring and other related charges, European Union Medical Device Regulation (“MDR”) costs, debt extinguishment charges, acquisition-related amortization and other non-cash charges, and strategic transaction costs. Colfax also presents adjusted net income margin from continuing operations, which is subject to the same adjustments as adjusted net income from continuing operations.

Adjusted net income per diluted share from continuing operations represents adjusted income from continuing operations divided by the number of adjusted diluted weighted average shares. Both GAAP and non-GAAP diluted net income per share data is computed based on weighted average shares outstanding and, if there is net income from continuing operations (rather than net loss) during the period, the dilutive impact of share equivalents outstanding during the period. Diluted weighted average shares outstanding and adjusted diluted weighted average shares outstanding are calculated on the same basis except for the net income or loss figure used in determining whether to include such dilutive impact.

Adjusted EBITA represents net income (loss) from continuing operations excluding restructuring and other related charges, MDR costs, acquisition-related amortization and other non-cash charges, and strategic transaction costs, as well as income tax expense(benefit) and interest expense, net. Colfax presents adjusted EBITA margin, which is subject to the same adjustments as adjusted EBITA. Further, Colfax presents adjusted EBITA (and adjusted EBITA margin) on a segment basis, where we exclude the impact of strategic transaction costs and acquisition-related amortization and other non-cash charges from segment operating income.

Core or organic sales growth (decline) excludes the impact of acquisitions and foreign exchange rate fluctuations.

Free cash flow represents cash flow from operating activities less purchases of property, plant and equipment.

These non-GAAP financial measures assist Colfax management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to discrete restructuring plans that are fundamentally different from the ongoing productivity improvements of the Company. Colfax management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.

CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements


concerning Colfax’s plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax’s results to differ materially from current expectations include, but are not limited to, risks related to the impact of the COVID-19 global pandemic, including actions by governments, businesses and individuals in response to the situation, such as the scope and duration of the outbreak, the nature and effectiveness of government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on Colfax’s business and ability to execute business continuity plans, and the other factors detailed in Colfax’s reports filed with the U.S. Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption “Risk Factors,” as well as the other risks discussed in Colfax’s filings with the SEC. In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. Colfax disclaims any duty to update the information herein.

The term “Colfax” in reference to the activities described in this press release may mean one or more of Colfax’s global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.

Contact:

Mike Macek
Vice President, Finance
Colfax Corporation
+1-302-252-9129
investorrelations@colfaxcorp.com





Colfax Corporation
Condensed Consolidated Statements of Operations
Dollars in thousands, except per share data
(Unaudited)

 
Three Months Ended
 
Six Months Ended
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
 
 
 
 
 
 
 
 
Net sales
$
620,360

 
$
908,647

 
$
1,436,716

 
$
1,592,566

Cost of sales
379,274

 
532,589

 
847,416

 
955,495

Gross profit
241,086

 
376,058

 
589,300

 
637,071

Selling, general and administrative expense
235,727

 
307,939

 
527,924

 
555,788

Restructuring and other related charges
10,280

 
26,585

 
19,460

 
37,416

Operating income (loss)
(4,921
)
 
41,534

 
41,916

 
43,867

Interest expense, net
28,284

 
33,171

 
53,080

 
54,992

Income (loss) from continuing operations before income taxes
(33,205
)
 
8,363

 
(11,164
)
 
(11,125
)
Income tax expense (benefit)
(30,063
)
 
6,151

 
(16,890
)
 
8,193

Net income (loss) from continuing operations
(3,142
)
 
2,212

 
5,726

 
(19,318
)
Loss from discontinued operations, net of taxes
(4,905
)
 
(468,817
)
 
(8,265
)
 
(495,289
)
Net loss
(8,047
)
 
(466,605
)
 
(2,539
)
 
(514,607
)
Less: income attributable to noncontrolling interest, net of taxes
427

 
2,629

 
1,454

 
6,650

Net loss attributable to Colfax Corporation
$
(8,474
)
 
$
(469,234
)
 
$
(3,993
)
 
$
(521,257
)
Net income (loss) per share - basic & diluted
 
 
 
 
 
 
 
Continuing operations
$
(0.03
)
 
$
0.01

 
$
0.03

 
$
(0.16
)
Discontinued operations
$
(0.04
)
 
$
(3.46
)
 
$
(0.06
)
 
$
(3.70
)
Consolidated operations
$
(0.06
)
 
$
(3.45
)
 
$
(0.03
)
 
$
(3.86
)




Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in millions, except per share data
(Unaudited)

 
Three Months Ended
 
Six Months Ended
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
Adjusted Net Income and Adjusted Net Income Per Share
 
 
 
 
 
Net income (loss) from continuing operations attributable to Colfax Corporation (1)
$
(3.6
)
 
$
1.3

 
$
4.3

 
$
(21.5
)
Restructuring and other related charges - pretax (2)
11.2

 
26.6

 
22.2

 
37.4

MDR costs - pretax (3)
1.0

 
—

 
1.9

 
—

Debt extinguishment charges - pretax
—

 
—

 
—

 
0.8

Acquisition-related amortization and other non-cash charges - pretax (4)
36.1

 
56.6

 
71.9

 
80.4

Strategic transaction costs - pretax (5)
1.7

 
2.5

 
2.6

 
55.8

Tax adjustment (6)
(33.7
)
 
(12.7
)
 
(36.3
)
 
(29.4
)
Adjusted net income from continuing operations
$
12.7

 
$
74.3

 
$
66.6

 
$
123.4

Adjusted net income margin from continuing operations
2.1
%
 
8.2
%
 
4.6
%
 
7.8
%
Weighted-average shares outstanding - diluted (in millions)
137.6

 
136.9

 
139.6

 
135.8

 
 
 
 
 
 
 
 
Adjusted net income per share - diluted from continuing operations
$
0.09

 
$
0.54

 
$
0.48

 
$
0.91

 
 
 
 
 
 
 
 
Net income per share - diluted from continuing operations (GAAP)
$
(0.03
)
 
$
0.01

 
$
0.03

 
$
(0.16
)
__________ 
(1) Net income (loss) from continuing operations attributable to Colfax Corporation for the respective periods is calculated using Net income (loss) from continuing operations less the continuing operations component of the income attributable to noncontrolling interest, net of taxes, of $0.4 million and $1.5 million for the three and six months ended July 3, 2020 and $0.9 million and $2.2 million for the three and six months ended June 28, 2019, respectively. Net income (loss) from continuing operations attributable to Colfax Corporation for the three and six months ended July 3, 2020 includes a $6.8 million discrete tax benefit associated with the filing of timely elected changes to U.S. Federal tax returns to credit rather than to deduct foreign taxes. The discrete benefit has been excluded from the effective tax rates used to calculate adjusted net income and adjusted net income per share.
(2) Includes $0.9 million and $2.7 million of expense classified as Cost of sales on the Company’s Condensed Consolidated Statements of Operations for the three and six months ended July 3, 2020, respectively.
(3) Includes costs specific to compliance with medical device reporting regulations and other requirements of the European Union Medical Device Regulation of 2017.
(4) Includes amortization of acquired intangibles and fair value charges on acquired inventory.
(5) Includes costs incurred for the acquisition of DJO.
(6) The effective tax rates used to calculate adjusted net income and adjusted net income per share were 21.5% and 22.2% and for the three and six months ended July 3, 2020 and 20.1% and 23.0% for the three and six months ended June 28, 2019, respectively.











Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in millions
(Unaudited)

 
Three Months Ended
 
Six Months Ended
 
July 3, 2020
 
June 28, 2019
 
July 3, 2020
 
June 28, 2019
 
(Dollars in millions)
 
 
Net income (loss) from continuing operations (GAAP)
$
(3.1
)
 
$
2.2

 
$
5.7

 
$
(19.3
)
Income tax expense (benefit)
(30.1
)
 
6.2

 
(16.9
)
 
8.2

Interest expense, net(1)
28.3

 
33.2

 
53.1

 
55.0

Restructuring and other related charges(2)
11.2

 
26.6

 
22.2

 
37.4

MDR costs(3)
1.0

 
—

 
1.9

 
—

Strategic transaction costs(4)
1.7

 
2.5

 
2.6

 
55.8

Acquisition-related amortization and other non-cash charges(5)
36.1

 
56.6

 
71.9

 
80.4

Adjusted EBITA (non-GAAP)
$
45.1

 
$
127.2

 
$
140.6

 
$
217.4

Net income (loss) margin from continuing operations (GAAP)
(0.5
)%
 
0.2
%
 
0.4
%
 
(1.2
)%
Adjusted EBITA margin (non-GAAP)
7.3
 %
 
14.0
%
 
9.8
%
 
13.7
 %
__________ 
(1) The six months ended June 28, 2019 includes $0.8 million of debt extinguishment charges in the first quarter of 2019.
(2) Restructuring and other related charges includes $0.9 million and $2.7 million of expense classified as Cost of sales on the Company’s Condensed Consolidated Statements of Operations for the three and six months ended July 3, 2020, respectively.
(3) Includes costs specific to compliance with medical device reporting regulations and other requirements of the European Union Medical Device Regulation of 2017.
(4) Includes costs incurred for the acquisition of DJO.
(5) Includes amortization of acquired intangibles and fair value charges on acquired inventory.







Colfax Corporation
Reconciliation of GAAP to non-GAAP Financial Measures
Change in Sales
Dollars in millions
(Unaudited)
 
Net Sales
 
Fabrication Technology
 
Medical Technology
 
Total Colfax
 
$
 
%
 
$
 
%
 
$
 
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the three months ended June 28, 2019
$
592.7

 
 
 
$
315.9

 
 
 
$
908.6

 
 
Components of Change:
 
 
 
 
 
 
 
 
 
 
 
Existing businesses(1)
(145.3
)
 
(24.5
)%
 
(107.9
)
 
(34.2
)%
 
(253.2
)
 
(27.9
)%
Acquisitions(2)
—

 
—
 %
 
—

 
—
 %
 
—

 
—
 %
Foreign currency translation(3)
(33.0
)
 
(5.6
)%
 
(2.0
)
 
(0.6
)%
 
(35.0
)
 
(3.9
)%
 
(178.3
)
 
(30.1
)%
 
(109.9
)
 
(34.8
)%
 
(288.2
)
 
(31.8
)%
For the three months ended July 3, 2020
$
414.4

 
 
 
$
206.0

 
 
 
$
620.4

 
 
 
(1) Excludes the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth due to factors such as price, product mix and volume.
(2) Represents the incremental sales from our acquisitions.
(3) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.


 
Net Sales
 
Fabrication Technology
 
Medical Technology(1)
 
Total Colfax
 
$
 
%
 
$
 
%
 
$
 
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the six months ended June 28, 2019
$
1,153.1

 
 
 
$
608.6

 
 
 
$
1,761.7

 
 
Components of Change:
 
 
 
 
 
 
 
 
 
 
 
Existing businesses(2)
(157.8
)
 
(13.7
)%
 
(106.7
)
 
(17.5
)%
 
(264.5
)
 
(15.0
)%
Acquisitions(3)
—

 
—
 %
 
—

 
—
 %
 
—

 
—
 %
Foreign currency translation(4)
(55.4
)
 
(4.8
)%
 
(5.1
)
 
(0.8
)%
 
(60.5
)
 
(3.4
)%
 
(213.2
)
 
(18.5
)%
 
(111.8
)
 
(18.3
)%
 
(325.0
)
 
(18.4
)%
For the six months ended July 3, 2020
$
939.9

 
 
 
$
496.8

 
 
 
$
1,436.7

 
 
 
(1) Medical Technology prior year Net sales and components of change are based on or derived from Management’s internal reports. On the Company’s form 10-Q for the second quarter of 2020, Medical Technology prior year Net sales include only sales subsequent to February 22, 2019, the date of the DJO acquisition, and sales prior to February 22, 2020 are included in the acquisitions line item of the change in sales reconciliation.
(2) Excludes the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth due to factors such as price, product mix and volume.
(3) Represents the incremental sales from our acquisitions.
(4) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.




Colfax Corporation
Condensed Consolidated Balance Sheets
Dollars in thousands, except share amounts
(Unaudited)

 
July 3, 2020
 
December 31, 2019
ASSETS
 
 
 
CURRENT ASSETS:
 
 
 
Cash and cash equivalents
$
66,396

 
$
109,632

Trade receivables, less allowance for credit losses of $32,376 and $32,634
449,672

 
561,865

Inventories, net
556,708

 
571,558

Other current assets
155,628

 
161,190

Total current assets
1,228,404

 
1,404,245

Property, plant and equipment, net
469,255

 
491,241

Goodwill
3,209,980

 
3,202,517

Intangible assets, net
1,650,705

 
1,719,019

Lease asset - right of use
171,082

 
173,320

Other assets
393,099

 
396,490

Total assets
$
7,122,525

 
$
7,386,832

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
CURRENT LIABILITIES:
 
 
 
Current portion of long-term debt
$
26,530

 
$
27,642

Accounts payable
298,986

 
359,782

Accrued liabilities
433,215

 
469,890

Total current liabilities
758,731

 
857,314

Long-term debt, less current portion
2,220,930

 
2,284,184

Non-current lease liability
131,214

 
136,399

Other liabilities
616,074

 
619,307

Total liabilities
3,726,949

 
3,897,204

Equity:
 
 
 
Common stock, $0.001 par value; 400,000,000 shares authorized; 118,389,013 and 118,059,082 issued and outstanding as of July 3, 2020 and December 31, 2019, respectively
118

 
118

Additional paid-in capital
3,462,532

 
3,445,597

Retained earnings
470,749

 
479,560

Accumulated other comprehensive loss
(581,484
)
 
(483,845
)
Total Colfax Corporation equity
3,351,915

 
3,441,430

Noncontrolling interest
43,661

 
48,198

Total equity
3,395,576

 
3,489,628

Total liabilities and equity
$
7,122,525

 
$
7,386,832









Colfax Corporation
Condensed Consolidated Statements of Cash Flows
Dollars in thousands
(Unaudited)
 
Six Months Ended
 
July 3, 2020
 
June 28, 2019
Cash flows from operating activities:
 
 
 
Net loss
$
(2,539
)
 
$
(514,607
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
Divestiture impairment loss
—

 
481,000

Depreciation, amortization and other impairment charges
120,038

 
120,469

Stock-based compensation expense
14,685

 
11,169

Non-cash interest expense
2,743

 
3,947

Deferred income tax benefit
(19,857
)
 
(17,412
)
(Gain) loss on sale of property, plant and equipment
(3,400
)
 
878

Pension settlement loss
—

 
43,774

Changes in operating assets and liabilities:
 
 
 
Trade receivables, net
89,231

 
(6,589
)
Inventories, net
352

 
(39,400
)
Accounts payable
(47,436
)
 
(62,831
)
Income taxes
(23,983
)
 
(33,637
)
Other operating assets and liabilities
(36,620
)
 
23,671

Net cash provided by operating activities
93,214

 
10,432

Cash flows from investing activities:
 
 
 
Purchases of property, plant and equipment
(50,426
)
 
(63,956
)
Proceeds from sale of property, plant and equipment
4,996

 
3,256

Acquisitions, net of cash received
(7,548
)
 
(3,147,835
)
Net cash used in investing activities
(52,978
)
 
(3,208,535
)
Cash flows from financing activities:
 
 
 
Proceeds from borrowings on term credit facility
—

 
2,725,000

Payments under term credit facility
—

 
(518,125
)
Proceeds from borrowings on revolving credit facilities and other
635,678

 
1,575,486

Repayments of borrowings on revolving credit facilities and other
(698,910
)
 
(865,357
)
Payment of debt issuance costs
(4,560
)
 
(24,280
)
Proceeds from prepaid stock purchase contracts
—

 
377,814

Proceeds from issuance of common stock, net
2,250

 
3,988

Payment for noncontrolling interest share repurchase
—

 
(93,087
)
Deferred consideration and other
(11,871
)
 
(2,417
)
Net cash provided by (used in) financing activities
(77,413
)
 
3,179,022

Effect of foreign exchange rates on Cash and cash equivalents
(6,059
)
 
6,268

Decrease in Cash and cash equivalents
(43,236
)
 
(12,813
)
Cash and cash equivalents, beginning of period
109,632

 
245,019

Cash and cash equivalents, end of period
$
66,396

 
$
232,206


 EX-101.SCH 3 cfx-20200805.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - COVER PAGE link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 cfx-20200805_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 cfx-20200805_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 cfx-20200805_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Entities [Table] Entities [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock Common Stock [Member] Tangible Equity Unit Tangible Equity Unit [Member] Tangible Equity Unit [Member] Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key EX-101.PRE 7 cfx-20200805_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 colfaxlogoa05.jpg begin 644 colfaxlogoa05.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X0 B17AI9@ 34T *@ @ 0$2 , M ! $ #_VP!# (! 0(! 0(" @(" @(" P4# P,# P8$! ,%!P8' M!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_VP!# 0(" @,# M P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P, M# P,# P,# P,# P,# S_P 1" #K ?<# 2( A$! Q$!_\0 'P 04! 0$! M 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4%! 0 %] 0(# M 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B7J#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! 0$! 0 M $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" Q$$!2$Q!A)! M40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4 ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/D MY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]_**** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **,T4 %%%&: "BBB@ H MHSBB@ HHS1G% !12,V*7- !11FC- !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %!.!10PR* .!^/G[1WA/]F;PE;ZU MXPU"33M/O+M;**1+:2?^">[_\ MC=?0?B?P9I/C?3UM=7TZRU2WC<2K'=0K*JL 0& 8$9P2,^YK$_X9\\#C_F4/ M#?\ X+8?_B:\7'4W_ O'_(T7W_@GN_\ XW0/^"N'P-_Z&B\_\%%W_P#&Z\#_ ."U MGP\T'P3X+\"MH^C:7I;7%[%^)$,J*68[G0+P!ZU[4(L3G>6?7,4HJ7,U[J:5DEW;[GXQXM<%X+A? M.UEN E*4'",O>:;NVUT25M%T'4'I117VQ^7D8XZTX_,WM1C!SW%<#^T)^T3X M9_9I\ W'B+Q/?+;6\>4@@3!GO9<$B.)"1N8X^@&22 ":PQ&)I4*7WC#5 XC$&C1"6,L3@#S6*HW_ MUZ5\1_&']JKX MH?\ !2'XL6O@WP^DVG:/J$^VTT:"7;$J#EI;J4#+!0-QR-JX&U=W7] ?V0OV M!_!O[*GANUDALX-7\5-%B]UF>(&5V/WEC!SY M2Q4:,79U9)N[[1CI?OJ_D?KF9<"Y7PKA85>)YRJ8FHKQH4VE9=ZD[.RZ>ZM] MFU<\@OO^"H?Q*NY/,TG]G7QM<69.8YY%NLR+CKA;4@?]]&LW3_\ @M;9Z!K! ML?&GPR\2>&KI3\T,=P)I57L2DJ0GUX]NM?:2U49 M0ARORNDFO6YX^5Y]PK7KQP^.ROE@VES0JU.>-^MI-QE;M9#?@)^V%\/?VE(/ M^*4\06MW=QKOEL908+J(=R8W 8@?WEROO7J YQ7\^7A_Q#J'A/6K?4M+O;K3 M]0M'$D%Q;3-%-"XZ%64@@_C7ZO\ _!,_]O*3]J+PM-X?\22PKXTT2+S)'4!? M[2M\A1,%' 9*'@E5 MX=P_]JY9-U<-I=/XH7ZNVC5]+V375=3ZQHHHK]7/P$**** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^!/^"[/'@K MP#_U_7/_ * E?F]7Z0_\%VO^1+\ _P#7]<_^@)7YO5_)/BQ_R457TC^2/]#/ M #_DC,/ZS_\ 2Y'TY_P2)_Y/9T7_ *\+O_T57[ 5^/\ _P $B?\ D]G1?^O" M[_\ 15?L!7[!X._\B%_XW^2/YQ^DA_R5D?\ KU#\Y!110>E?JQ^ G,_%;XG: M-\&_A_JGB;7[I;/2]'A,\TCOQ9_:S_:EUS]K+XJW.OZ MJSPV,1:+3-/5\QV$&<@#L7;@NW\1] % ^JO^"V7[0DUWXDT/X;V,[QVMK$-4 MU15;Y9G8E84;V4!V(/!+(>JBO@6OYH\6.+*N)QG]CX=VIPMS?WI;_Y_; M7T??#VC@LN7$>,C>M53Y+_9AM=>OG+_ (*;?M+_ /#._P"S??)9F1=;\4%M*L"I MP82ZG?+_ , 7./\ :*]J^CNH-?#O_!:CX(>(_B1X%\(>(-#L+S4[?PW-=17L M%K$TDBK/Y6V4J.=JF(@G!QO!X&:GC+$8K#Y+B*N#31TY12?5N+22\[O0_6M&W(I]1FEI%7 _#%+7]KG^9(4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%&<49H **** "BC-% !111 M0 4444 ? G_!=K_D2_ /_7]<_P#H"5^;U?I#_P %VO\ D2_ /_7]<_\ H"5^ M;U?R3XL?\E%5](_DC_0SP _Y(S#^L_\ TN1].?\ !(G_ )/9T7_KPN__ $57 M[ 5^/_\ P2)_Y/9T7_KPN_\ T57[ 5^P>#O_ "(7_C?Y(_G'Z2'_ "5D?^O4 M/SD)G:M)*VR%F] 301SBJ/B74AI7A^]N#]V"!Y#GT"D_TK]4J2Y8ML_!*<7* M:BMV?A_^V9\07^*'[5/CO66_Y;:O-;Q'^]'"?)0_]\QK7F=27=W)?W/!%G#N\FUT*RACW')VK!&HR?7 KNQS7(?L^_P#)#O!_ M_8'M/_1*UUZ&O[CP,5'#P2VLOR/\L\TE?&56_P":7YL<.*;)$KKAE##T-.HK MK.$Y76?@SX2\17K75]X;T.\N&^]+-812,WU+*3706&G0:9;I#;PQP0QC:J(@ M55'H *L*>*,9%91HTXN\59FU3$UJD5&I)M+9-O0=11FBM3$**** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **,T9H ** M,U'-26;I1>VX:O8?T'7]*0+GO7D/Q(_;M^$OPJGFBUCQQHL=Q; M-ME@MIC=S1GT:.(,P/L17FVK?\%AO@OIX8P:GK-]R /)TN4;OIO"UXN(XBRN M@^2KB()]N97^Z]SZ7!\&Y[BX^TPV$J2CW4)6^^UCZG/-!&ZOF/2?^"NGP0U& M55E\0:A9[LHI<\UZYX 4444 %%%1O*L:%BRA<9))Q@4 .SN-!7(]*\#^,7_ 40\ _" M^XDLK&ZE\4:I&2IATXJT,;>CS'Y/;Y-Q'I7AOB/_ (*9>-_$TS+I.F:/H<#? M=W(UU,O_ )B%/\ WQ7;1R^O45TK+S/%Q7$&"H2Y93N^RU_X!]W!10<+7Y\V MW[6OQ,UM_P!]XINOF()\JW@BQ]-J"NL\-_M-_$"%EW>(;B8+VE@A?=]89/S MY7_QVO7?!OQET?Q@%C61[.X/_+*X&W)]FZ'\\^UAV%%"MN%%<9Z@4444 ? G_!=K_D2_ /_7]<_P#H"5^;U?I#_P %VO\ MD2_ /_7]<_\ H"5^;U?R3XL?\E%5](_DC_0SP _Y(S#^L_\ TN1].?\ !(G_ M )/9T7_KPN__ $57[ 5^/_\ P2)_Y/9T7_KPN_\ T57[ $XK]@\'O^1"_P#& M_P D?SC])#_DK(_]>H?G(:_2L'XH'_BWNN?]>$__ *+:MIKZ$_\ +6/_ +Z% M8/Q/O(3\/=<_>Q_\>$_\0_YYM7Z;B*D?8RUZ/\C\-P,7]9IZ?:7YGX#T445_ M!W_+[Y_J?ZOQ_P!W_P"W?T/WK_9]_P"2&^#_ /L#VG_HE*Z_NM<7^S]>1K\$ M/"(:2,'^R+3(+#_GBE=A]NA^7]]%_P!]"O[NP=2/L(:]%^1_E)F<9?7*NGVI M?FR:BH3?0@?ZZ/\ [Z%2HZR+E2&'J*ZE)/9G!RM;B$YZ4['% &*KW5_#80L\ MTD<<:@EF9L!0.N2:;:2NPC%MV1-G/:CH?>O$/B#_ ,%%/@[\,YWAU#QSI4TR M.8C'8![YE89RI\D-M/&/FQ@]:X/5?^"Q?P9L1F"_UN\^;;^ZTQUX]?GV\?KS MTKQ*_$F54I(-1M>G,FDW) _[Y0G]*]=^&/[4WP]^,LGE^&?%VAZM M<;=_V>&Z7[0!ZF,X<#_@-:X7/LNQ,_9T*\92[*2O]U[G/C^%,ZP,/:XO"5(1 M[N$DOOM8]"HIJR*XX.:=FO7/GPHI&;:M1&_A'_+:/_OH5+DEN-1;V)J*A^WP MY_UT7_?8I?MT(_Y;1?\ ?0H]I'N/EEV):*B^W0_\]HO^^Q1]NA_Y[1?]]"CV MD>XT7_ M 'T*7/'N5ROL2T5%]NA_Y[1?]]BE%Y"QXEC/_ A1[2/<.5]B2BA6W"BJ)"BB MB@ HHHH *#110!'MVK1G9UIQ&5KXD_X*<_\ !1%_@W;S^ ?!-XO_ E%U'C4 MKZ-LMI*, 0B?]-64Y!_@4@]64CQ\\SS"Y3A)8O%RM%?>WT2[MGT7"O"^/X@S M&&6Y?&\Y;M[12WDWT2_X"NVD=_\ MD_\%-?"/[,#3:-IVWQ-XOC #6$$NV*S M)Z&>0 [3CG: 6Z9"@AJ^#1\7OC5_P4B^*$?A>/6)GBO@7DL+9FM=-LH1C22>>9S)))(Q9I&)R6)/))/4FOUV_X):?L MR0_ ;]G>SU:\M?+\1>,$34+QG0B2&(C,,/."-J-DCLS-[5^'95G&:<:9HZ$Y M.GAHZRC%VTZ)OJW]R5[']39[P[D7AGD*Q=.FJ^/J/EA.:3L[7I M'^S_ /\ !*#X8_"308?[>TV/QEK94>?=ZBN82W<)!DHJYZ;MS?[5>\:'\$/! M_AFQ6UT_PQH%C;QC"QP:?%&JXZ8"J!75 ;?I3B<]Z_<\#D> P=-4\/2C%+LE M?YO=G\JYIQ1FV8UG7QN(G.3UUD[+T6R7DDD>;_$;]DWX<_%:T:'7?!V@7WR% M%D^QI'-&#P=DB@.O;[K#H/2OSM_X*(_\$Y8_V6K"+QIX-NKR3PT;E([BWF?= M+I4C']VRR=60MA1GYE.WEMV1^K#S2=[JST['Q1^RM_P52\>_ F_M;#Q%=7 M/C+PRK*CPWDVZ\MESR8ICRV!_!(2. 4ZU^I/P:^,>@?'CP#8^)O#=\E]IE\ MN58<-&X^\CKU5E/!!_E@U^"=?4'_ 2K_:9O?@O^T3I_AVXNF7PWXTF6QN(' M?Y([D@B"11_>+8C/3(?G.UZ_7P,?%V MG^!/#%]K&JW4=GI^FP/)+^.QT^VX!/S23N<[8XUZLYQP![DX )K\Y_V@_VU/&W[6>O2:+I M,%]IOAN9RD&D6(9Y[Y>QG*\N3UV#Y!QP2-QN?M._%.U^,5U'\2_BUJU]X3^' M46]/"WAZW4/J^NQC^.")CM7?\I:=_E'RJ,C!KY-^+?\ P4N\:3Z?<:+\,;&S M^$WAIU\K&C'=JUVN" 9[\CS2W)/[O8!V'&:G$YYE^6:57S5?Y5T]33*> ^(> M*E[3"KV6%_FE=&+.0!A+KNI6VF8SP,K,ZM MUXZ=35SP]X2\,WFI_8;/XJ?!J_U!20UI:^-].DG&#AOE\S/'>ORQ\<-J'C35 MY]1U:^O=4O[@[I;F[G:>:4^K.Q))^IKAM;\(;U/R5P_Z]59OW(*Q]/\ \0&P MV'A:K6DWZ)'[F1? 'Q1H>F1WC:1-/?V=]>75/ 7C+Q/X0O4E68R:3J,MJ)67&/,56"R+Q@JX((R""#BON3 M]DO_ (.!M0BU.UT/]HCP_'KUHY6(>,] LX[;5+7) WW5LFV&X0=28U1P!P'8 MXKV,!QC2F^7$1Y?-;'R6<>$V)PT7/!SY[='H_P#(_2O0=)Z<5U^GVJVL.[TK M-\!:AHOCKP=IGB;PQK6F>)O"VMQ^;IVK:?*);>Z0'!YZJZD$,C896!!&15W5 M[\11[>@%?;4:D:L5.#NF?EF(I5,-)PJJTET9T_A/XZ77A&Y2&\WW>G]".LD( M]5/<>Q_#%>RZ'K]KXCTV.[LYHY[:9:O_ :^/8H]1W]0,=<8\W,,I4HNI16OY_\ !.K*>+'0JJAB MG>#TOV_X!]>(9&R_ MW@17Y _\$B?^3V=%_P"O"[_]%5^P%?K_ (/ZY"T_YW^2/YR^DA_R5D?^O4/S MD?%?_#CKX9JW_(R>.L?]?5K_ /(]9?B__@BG\-_#OA?4KZ/Q'XV:2SMI)D#7 M5KM)52PSBW!ZCUK[F)R16%\4!_Q;O7/^O"?_ -%M7U&(X,R7VG!XR=KKKYGX!4445_&G*O:V\_U/]+%)^QYNMOT/TH^&7_!&;X<^ M-OA[HFKS^(/&T<^IV$%U(D=U:A59XU8@9MR<9)QDGZUO#_@AY\,_^AD\=?\ M@7:__(U?4?[/Z_\ %CO!Y_Z@]I_Z(2NP[5_9.%X+R25&$GAXWLN_^9_FMF'B M/Q+'%5(QQDTE)VU\SXL_X<=_#7/_ ",GCC_P+M?_ )&KZL^#WPLLO@K\,]%\ M*Z;/=7%CH=LEK!)QE^19?ESE5PM-0NM6NQ\YFW%&;YM"-''UY5$G=)]'L>-_ME_MJ>'_V/? JW ME\!J.O:@&73-+CDVO=D:Y&6P>N ":_*']H;]L;Q]^TYJLTGB37+AM/ M=LQZ5:L8K&$9! $8/S$$##.6;WJI^U;\?+[]I3XZZYXJNI)&M[J8PZ?$_P#R M[6B$B-0.W'S'U9F/>N&\.ZA'I.OV-U/%Y\-M<1RR1X!\Q58$KCIR!BOYIXTX M[Q6;X]X6A4<,.G9)?:7=][]%L?W!X8^$^ X>RR./Q5)5,7*/,VU?D=K\L;[6 MV;6K=];:'Z;?L9?\$G/"/A+P1INN?$+3_P#A(/$=]$MP]C<'_1-/W#(C,8XD M8 X8MD9S@<9/U9H'P0\'^%]*2ST[POH%C:Q_=B@T^*-!]%"@=A72:RN_-O=L_B?B#C#-\WQ<\3C:\F MVVTKM*/DELDO^'/-/B=^R%\-_C!I\EOKW@_1+MG0QK.EJL5Q&#_=E0!U_ ]J M_+#]O?\ 8YN/V-/BM:#3;JZN/#VK;KC2;MSB:%T(WQ%ACYD+*0PQD,#U!K]F M67>*^3/^"R?@.W\3_LBS:LZXN/#FIVUS$V.TC>0P^A\W\P*^4\0^&,)B\JJX MJ$5&K33DI)6=EJTVMU:^Y^@>#O'.88#/Z&!K5'.A6DH.#;:O+1-)[.]KVW5U MV/EC]CG_ (*O^*OA!JEGHWCJZNO%'A9F$1NI3YE_IZ]-P?K*H[JV6]&XVG]2 M/"'BS3O'GAJQUC2;N&^TW485N+:XB;U^E[7_(_EG)^)LTRI2675I4^:U^7K;:_H?DW_ ,%! M_P#@FS'^REX;L/$WA6]U;5_#;.+;4/MS(\UE*Q_=ON1$7RVR%Y7(;')W #Y* MK^@#QUX*TWXA>$-0T/5K6.\TW5('MKF&0961'!!'Z]>H.#7XG_M>_LQZG^RC M\9K[PW>^;<6#?Z1IEXR_\?=LQ.UC@8WK@JP'\0..",_SUXH<&O+:D<>J]8_BK=FSS6P:W2_@^U)+); M!U,RQ.$=ER-P5B&"L1G!*D ]CTK]&/@S_P $F?@Y\4_VAP_5E3J4;MQCIS1ZZ6^*.Z[JZU=CZP^$?\ P2&^'_P=^)>B^*-/UWQA M<7VAW2W<,5Q$P M--T\)!1BW=I=^Y_ ^<9]F&:556S&JZDDK)RZ+L?+O[07_!*WP)^T;\7M8\9: MQK?BRTU'6#$9XK.XMUA3RXHX5VAX68?+&I.6/)/3I7B_[07_ 2R^#?[.?PL MU3Q5KGBCQT+338BRQ+>6GF74AX2),V_WF; '8/C#4]0_X*L?M;1Z%I\EQ'\)? LV^YN(R56_;)!8'CYI,,B]UC M#-P6(KXOBC)\JI+]WAXSQ%9M13OJWJY/R6[?R/TK@3/<^Q,OWV,G3P>&BG-I M[16BA'^]+2,5OUZ'!_L&_P#!,"V_:9\$7GBSQ9=:YH6AW4NS18[.6-9[E5)W M2LSQL"O\(PHW$,> !GZ-\)?\$8?ASX/\5:9JUOX@\;23Z7=17D:R75L49XW# MJ& MP<9 S@CZU]:^'?#]GX5T.TTW3[>&SLK&%8(((@%CB10 .@ J_P!_ M6N_)^ \JP>'A"I34IQWD]V][_?LNQY?$7BMG^8XRK6I5Y4Z(?$%[XKUZ^U34KB2\U#49WN+B M>0Y:61V+,Q]R237U]_P6A^-TGC/X_:?X-@G+6/A*T62:,'@W4X#'(Z'$8CQZ M;V]37QK7\H^*W$4\=FCP<'^[HZ6[RZOY/3Y']]> /!E/*L@CF=6/[[$VE?JH M?97HU[WS\CN?V9_A0N M#7Z7X,8!4\JJ8E[SE;Y12M^+9^)_26S:5?B"C@4_=I4T_P#MZ3=_P2'48HHK M]C/YQ&$XK\YO^"Z'CR:36? OAJ.3%O'';^9]J_1C+#_/ M2OF[_@H-^P8G[8^@:;=:?J4>D^)-#606LDR,T%RCX)CDQROS*I# $CG@YX^0 MXZRW%X_):V%P2O.5M-KI--KYI'Z%X59WE^4\3X;'YF[4HMZVO9N+2;2UM=_+ M<_'C%=;\ TED^.O@M;?<;AM>L1&%Z[_M$>W'XU[/J_\ P23^-VG:RMK#X=L; M^$G!O+?5(!"ON1(R2?\ CE?4/[!'_!*JZ^"7CNU\9^/+RQO-8TTEM/TZT+20 MVSD8$KN0-S@$X4# )W9) Q_.7#W .=ULQIQJ4)4XJ2Q]PVQS"F?[H_E7RS_P %'_C;HW@3 MP<[^(%6^\-Z!-'--I0D"_P#"2:F0)+:Q;TAC4">;@_*8L DXKZFE9849CP%! M)X[5^,?_ 4X^/D_QR_:)U#3K>X9]"\)S36%L@8E)+C>3(OVAOB+>>)O%%Y]LU&\PB(J[8+.(?<@A3.$B0' 4>Y.223P5WIW% M=/<6>,\53N++-?SQ@N**E6HYU97D]6V?WG4X9P]"@L/AX*,(JR25DDMDCD+[ M2MW;\Z^J?V2/^"(_Q&_:BTZUUS79(O 7A6[ DBN;Z R7UU&<8:*VRIVD=&D9 M,@@@,#7O7_!'[_@G78_$J>/XJ>-; 76DV=P5T"QF :.[EC;#7#K_ !*CC:JG M@LK$C &?U/ VC' _"OWGA7*)U\/'%8K:6J7==WZ]#^2?$[CNGA,;/+,K2!_\ @W0^ ^@VA&N77C+Q-<,/F:XU)+>,'_96&-2/Q9NM M87Q@_P"#9SX$^/-/D/AW5_&WA&\P?+,=Y'>V^2 7CE3><$9XD7J?;'Z,J.* M4G%?;?4:%N7D1^(2S[,)2YW5E?UT^[8_%CX;?LP?'G_@@_\ $:ZU>[\SXI?L MXZO,!XF720^[3$P +_[,Q+6T\>Z^TEO==^OF>;ZYJ>XGFN0UG4 M"S<5=UO4^#S6#))YKY-?H,3^<<9B')V1]5_L-?%Q]>\.W'A>]DWW&DCS;0M] MY[ZY_P!>$_\ Z+:OT_$?PI>C/PO _P"\T_\ $OS/P#HH MHK^#/^7WS_4_UAC_ +O_ -N_H?O7^S[_ ,D-\'_]@>T_]$I77Y^[7(?L^_\ M)#?!_P#V![3_ -$I77]UK^\,'_ AZ+\C_*+,O]\J_P"*7YL,9KE?C=;W%W\' M_%$=J'^TR:5RJQJ MV^%I_<[G\\]%?I=\:O\ @B;HWC7QE>:IX5\62>';:^G>=["XL!=10ECG$15X MRJ@YPI#<$<\57^$'_!$#2?#/C&VO_%GBYO$6GVLBR?V?;V'V1;@CG;(QD<[# MW"@$^HK^4I>%/$"QGLU37+?X^96MWM>_RM?R/[ZCX_<(/+O:RK/VG+\')+FO M;X;VY;^=[>9]>?LW:]>>*?@#X+U&^C>*\OM$LYYXW&&1W@1F!X'()/85VX^4 M8J*UM8["UCAC58XXU"JJCA0. *FZ9K^J;16 M;_2/$^I6UM$HZ@1.+AF^@\H#ZL*\3BZI&GDF*E-V7LY+YM-+\6?4^'F'J5^) ML!"FKOVU-_)23?W)-GY-5[1_P3Q\5-X-_;/\ 77F>6)M0^QM\V XFC>+!]?O MCCUQ7B]=Y^RR?^,GOAO_ -C1IG_I7%7\><.UG2S3#U([J<7^*/\ 1WC*C&KD M.-I3V=*=_P#P%G[O1/O4?2G8IL'^J3_=%.K^Y8['^6+&8RU>#?M^?LA6W[6' MP8FL[>.&/Q-I&ZYTBY<8VR8^:)CUV2 ;3Z$*V#MQ7O0X-(WS#_>KBS# 4<;A MIX7$*\)*S7]=>QZ63YMB0R M6MY9S/;W$,B[7BD1BK*P[$$$'Z57K]!/^"P7[%GV2=OBMX$?\ X ?[QK\^Z_C'BKAVODF82PE39:Q?=/9_Y]F?Z6/M%D2XU;Q%$UMI>G2C< 'YU-?OOA_Q]1Q65RAF$K5*$;MO[45HGYOH^[]3^2?%[PDQ6"SVG M5R>GS4L5*R2VA-ZN/9+=KHDFM$CC?^"E'[2NK>-_$VG_ )^';?:_%'BAUAU M=XGQ]EA9=WDEA]TLF7<_PQCH=XQ]$?LG?LSZ/^RO\(=/\-Z6%EN%'G7]YLVO M?7# ;Y&_(*!V55'.*\9_X)I?LD:A\/='O/B7XX\Z[\>^-,W+FY7][80N=VT^ MDDAPS], (N!M.?K8#!QFOK^'\%6KU99QCE:I-6A%_8AT7J]Y?=T/SOB_-,/A M,/#AO*I7HTG>I-?\O:NS?^&/PQ797UT8['-% HK[ _.PHHHH **** "BBB@ MILS;86/H":=4=S_Q[2?[I_E2EL..Y^%O[7?C&;QY^U#X^U.9E9I=H-IG[&/Q! M94\POI4D1'H'PI/X D_A7XHGD5_-?CGB9/%X:A?11;^;=OT/[0^BU@5' 8W& M6UE.,;^45?\ ]N*DUH&%+H/@^Y\6^)M/TFSV_:M2N8K6'<< R2.$7)^I%6L9 MKM?V9;9+K]I/X>QL-RMXETU2I. 0;J/\:_&?"?X>6/PH^'&A^'-+C,>GZ+916<"_["(%&?4G&2>I))-= M*1BF0?+!']!3\\5_>U&$:<%"*LEHC_)RM5G5J2JS=Y2;;?=L=1116AD-W<5G M^)M$B\0Z#=6,V/+NH7B/&>&4J?T)'XUH ?+S4=Q($@9B0 JFB-^:Z,ZB3@U+ M8_-S5)'%Z\;_ "M&Q5@>Q'6J^[Z?G4^M:@-4U>ZNA&L0N9GE$:]$W$G ^F:K M[O:OTZ%^74_E.LU[25M1>/:OT8\":U_PDG@O2=0SD7MG%.3_ +R!OZU^EMHOPT\/V;<-:Z=;Q,#URL:C^E?-\26Y8/KJ?J'AA*7M:Z6UE^I\2 M_P#!=K_D2_ /_7]<_P#H"5^;U?I#_P %VO\ D2_ /_7]<_\ H"5^;U?P_P"+ M'_)15?2/Y(_UL\ /^2,P_K/_ -+D?3G_ 2)_P"3V=%_Z\+O_P!%5^P%?C__ M ,$B?^3V=%_Z\+O_ -%5^P%?L'@[_P B%_XW^2/YQ^DA_P E9'_KU#\Y"'^E M8'Q/_P"2>ZY_UX3_ /HMJWV_I6!\3_\ DGNN?]>$_P#Z+:OT_$?PI>C/PO _ M[S3_ ,2_,_ .BBBOX,_Y??/]3_6&/^[_ /;OZ'[U_L^_\D.\(?\ 8'M/_1*5 MU_=:Y#]GW_DAO@__ + ]I_Z)2NO[K7]X8/\ @0]%^1_E%F7^^5?\4OS8ZC%& M:*ZCA&@>]!7%-DG6%=S,JCWKQ7XP_P#!0CX3_!*>2VU;Q;8W&H0DHUGIX-Y. MK#^%A&"$/^^5KCQF/PV%I^TQ-2,8]Y-)?B>AEN4XW,*OL<#2E4GVC%R?X)GM M@X%-,JQC+%1[FOSZ^('_ 6GU#Q;JBZ1\,_ =YJ&H71*6TE^#+-(W. MM"2S M>OW_ ,*CTW]FK]IW]LAO,^('BZ7P+X5.-Y-^6A]._M M!_\ !0/X9_LZVMQ'JFO6]_K$((72].87%TS_ -U@IVI]7*BOSM_:S\5?$+]L M3PQJGQ:U[2IM \%:#Y=EH=K)NVRF:5 3&2!YF1RT@ 7*HHZ''W;\ _\ @EK\ M*_@CY-U-I+>*=7A(87FKXG56ZY6+ C7!Z$J6&!\U97_!7BVCL_V)M62.-8XU MOK(*JC \Y>*\+BK+'^>9%E M6?X7"Y'3E5JU*D8NM4LK1;2DJ<%>UUIS2;:3:ZGY&UW?[+?_ "HVMQNQ7[89X->-_MQ_LSZ3^TU\!]4TJ^DAL[^P1KW3=0E(5;* M9 2"S'^!AE7_ -DD]0#7P/B!PG#.LN;BOWM.[B_S3\G^#LS]9\(?$&IPQG"] MJV\/5M&:[=I)=XW^:NM['XEUZM^Q3X@\):'^TKX/F\=+)+X;M[W>%>0"WM[A M@!')(N""@<1EN1]T$DJI4^63P_9IW3*-L8KN0Y4X[@]Q3*_DS+\9/!XN&(Y4 MW"2=GL[.]GY'^@><9=',LOJ81R<54C)*2=I+F5KI]&KG]"MNZ/ ICQLQQBI< MXKXK_P""2G[:/_"V?! ^'WB"X)\0^&X ;&:5LMJ%H/E'N6CX4^JE3SAC7VIG M)XK^V,PS]V2^Y]4_-,_P Q.*N&\9D.9UTEY-:_ M@]4.HH%%>P?/!1110 4444 %%%% !39UW0./52*=2/\ =H>N@(_"C]KCPE-X M'_:?\?:=.JQM'KMW*BJ,#RY)&DCX[?(ZUYW7U_\ \%F/@U)X'_:3M_%,4.VQ M\86:LT@!YN8 (Y!Z?ZOR3[DMZ5\@5_$?%V7RP6<8BA)?:=O1NZ_!H_T_\.LX MIYGPW@\73=[TXI_XDN5KY-,^S/\ @B-KOV/]I;Q!8;5_TS0'EW%L',<\(P!W MR)"?^ U^IQ'%?C[_ ,$DO%J^&?VV-!MY-P76K.ZL>_E =^2/K7[ M!!LU_17A%B%4R!03^"4E^3_4_C3Z1&#E1XNE4E_R\IPE^!Y?B5^SAXVT.W7==:CHUU% OK)Y3;/_'@*_"G. MZOZ$O-6]M-RE721,J1R"#T(K\0OVU?@I-\ /VE_%'A]H]MG]K:\T\[-JM;RD MR(%]=H)0GUC;I7X#XXY5*=+#YC!:*\7\]5^3/ZR^B[GL*>(Q>45'[TE&5_> K?^&FL3^$_'.CZW#'NFTB]@O8U)P"T4BN.?JM8MI:&[DVUVGA? MP_DKQ7XOP[E\Y5HXAZ,/#EGJ5E, MDUM=0I*C*0=RLBNIX]596'LPK7/WJ^#_ -E#]JR_^&GP=MM0N([C4M/\&JMG MK]I"N^X&F$GR+Z)<@$V[L8I !S$4)/R"OM3P+\0=%^)OA>UUOP_J5IJVEWR; MX+BVD#H_J/8CH5."#P0#7]N99B5B\%3QE/X9+[GU3\TS_*_/L$\MS6MEE7XH M/3SB]FO)HWJ*3>*"PKL//$S@UYS^U#\1H?AK\'-4N/,\N\OD-E:@'YC)(",C M_=7UT>SS'I]JQYC0]7?!(WM@9QP, #.,GULIR^>(JJ37NK?_ "/CN,.( MJ67X25.+_>25DNU^K].AB*VY:6J5A>[EJZ#D5]\?SQN;'@'PL_C7QKI>E)_R M_P!RD3'.-BD_,Q]@N3^%?HQ;IY4:KTVC&*^2?V,_ !7Q3:ZQ<1_OKP2+9JP! M*P)@3SX/5262 ?\ 79R/N&OK@\#]:^&SW%*K7Y([1T^?4_>O#W)YX3+_ *Q5 M5G5=U_A6B^_5_#O\ R(7_ (W^2/YQ^DA_R5D? M^O4/SD(?Z5@?$_\ Y)[KG_7A/_Z+:M]OZ5@?$_\ Y)[KG_7A/_Z+:OT_$?PI M>C/PO _[S3_Q+\S\ Z***_@S_E]\_P!3_6&/^[_]N_H?O7^S[_R0[PA_V![3 M_P!$I77_ -VN0_9]_P"2&^#_ /L#VG_HE*Z_NM?WA@_X$/1?D?Y19E_OE7_% M+\V!Z5Y_^T9^T3X?_9D^&=YXF\13LMO;X2&WC ::\E.=L4:]V.#[ DD $UW MQ Z^E?DS_P %?_CO=_$C]IB7PM'-)_9'@V%+=(_X)+F5%DDDZ\D!D7GIM..N M3\UQMQ(LDRN6+BKS;Y8I[%_!+XHSR&7S;5-)RFUORIK1>;;2\K MWZ'#_M1_\%$?B!^TSJ-Q!)J$WA_PVSD1:383-&CH1C$T@PTI(Z@_)Z**\_\ MV$]#55N+S,MQ<."4M(%(WRM[#( '+I(?]-U741812$Y_<0HK<>F7D;/KM'H*_G#AG#XKBG/8T\QJ.2UE M+7HNB[7=EIM<_M#C;'8'@/A:I5R>C&G)6C"R^U+2[ZMI7;O>]M3Z6_9B_8]\ M&_LK^%EL_#^GQMJ$B 7FIS@/=7C#J6;LN>BKA1GIG)/JFT#'\L5(.E&#GI7] M:8/!T,+2C0P\%&,=DM$C_/?,,RQ6/Q$L5C*CG.3NW)W;_K\! GR_A7RY_P % M@V_XPJUC_K_L_P#T>M?4C'@?2OD/_@L_XE71?V2HK,_>UC6K6V4;&/"[FZ^('BH?9].@A'F26:N=GG[<'+;CM12/F?L0I%7O^ M">G[%\?[,7@*35M<_P!.\=>)E$^JW3MYCP@G<(58\X!.6/\ $^220%Q\5G.( MJ9EBO[&PCM!6=62Z)[07G+KV1^F<-8.CD>!7$N8Q4IMM8>#^U);U)+^6'3^: M5NQ\N?M^_P#!,>P^"OP.T?Q)X*BN+C_A&[80Z\&)9[M,EC=D=B&)# GPZQITUK$]<+7&D3L2PCY^>W9O[T9(QGDHP.2LD]91?FMUY76R/(/AG\1=6^$? MCW2_$FAW!M=4T>X6X@D[$C@JPXRK E6'<,1WK]L_V5/VB=)_:?\ @_IOBG2V M6.2X7R[VTW[FLKA0-\3?0G(.!N5E;'-?A?7T'_P3L_;"F_94^,<:ZA,Y\)^( M'2VU6//$!SA+E1ZH3\WJA;@D+7@^&/&']DXWZIB'^YJ/7^[+H_T?E9]#ZSQO M\-UQ!EG]H8*-\313:[SCNX^JWCYZ=3]F:*JZ?J$6IV<4\$B30S*'1T8,K@C( M((X(([U:S7]8)W5T?P%*+3LPHHHH$%%%% !1110 4444 >*?MU?LPP_M5_ 7 M4="B$:ZU9_Z;I,SG:([E < GLK@LA] V>PK\6-7=KH?T5X%^*-+(L0\GS M2=L/4=XR>T)/1W[1??H]=FV?F_\ !3XCS?"#XM^&_$\+2;M#U"&\=4ZR1HP+ MIS_>3\D?.!U*8P/E8U\=X0\01P>+JY3BGR\^L;_P RT:]6OR/T MCZ17",LRR^CQ!@5S>RNIVUO"6JEZ)_@[[(^[J*16W"EK^D3^+0H)P*"V*0-D M4 -[5\&?\%'M9D_:?_:F^'?P/TE_.AAO%U'6C&W^J!4GD]F2W\YO?S4KZ!_; M1_;3T/\ 94\"M\R:EXKU13%I.E(V9)G/ =@.5C!ZGJ3P.:X/_@G/^R=K7@%- M6^)WQ"\ZX^(7C0F247'^MT^!V#;".BLQ"DJ.%"H@ P17Q>?5O[1KQR?#:JZE M4?2,4[V?G)JR7:[/TKA+#_V+A9\2XQ6:4HT(O>=1JW,EUC33;;VYK).Y]2Z; MI\>F:;!:PJL<=O&L:*HP% & !]!7Q_\ \%Q?J2*^R3\IJ.>W6=&1U5U88((SD5[F=9-A\SP,\!B%[LE M;T?1KTW/EN&.),7D>:TLVPK]^F[V[I[I^35T?@QX9T#)!Q7HOAG0>5XKZ/\ MVVOV$6^#_B:X\5>&+1F\*WTOF3V\8S_9&JJUON:[H_M./'6&SS!QQN$E=2Z=8OK%]FO^"M#IO@_XCO? MAKXHM]4L/+9D#1S02KNANX6&V2*1?XD9201^(P0#5CQYX1\8?LO27GQ*^"6M M:I;>"=0<2ZGID1$[:#*>?*N(6#*\(Y"3$' ."0>6?H^F[0.*[#P?XZU#X9:B M+_3;IK>?;L=<;HYD/574\,I]#6/"WC-+A;&^RKQ]IAYOWH]?57TO^9^#^)OA M[0XIH^UIS=/$0^&:T?H[:V,GP1_P6;\L>'?#>J.HP)8?,M6;W8;F4G MZ "K_B7_ (*]>.O$-OY>DZ/X?T7S%(,A22YE0]BNY@GYJ:YWQY\'OA3\:IWN MXW;X7^))CEVM; M@:I#=*?^ $K*#[%*_L/A?BWA#/Z2KX"I"[U<6[->J;_0_C#B?AWCO))NAB5- MPZ2BKI_-*Y5\7_&3Q%\6];&H>(]8O-6N\$(T[_+$#U"(,*@]E %2:5J7S=:A ML/V9OB=;7OV=_A_XT$FX+D:-<%,_[P3;CWSBNVT_]E7QMI%E]L\16NF^#]. MR]YK^HP6,48]P[;S^"FOMZV.P-"G=U(QBO-)'YS3R?-L=5Y51J2FW_+)MO[B MGIU_DCYJ[C3H=)\$> Y_&WC:Z?2?!^GN%&T?Z5K,W:UM$XWR,1@GH@R2< UY MUXQ_:+^$W[.5G)]ENI/BMXJC)$<%LKV>AVKC',DK 2W !Y 0!6 ()'6O6OV$ MOV8?&G[7WQ(TOXW?&4EM+TW$OA'P^81#:1*,&.5(/NQPKA3&/O2%5=B0 7_. MI]0R9^TJ/>2^&*[M]?)+J?M?"?@EBL/36<<4KV-&.U/[$)O%WBJQCTGQ!XJCB:/2D_U?A_3HPWV2P7ON179Y">3++)V M ]F P?K35'R_I3NAK@I4W"/*W?S>[?5OU/LZ]15)\R22Z);)+9+R2/@;_@N MU_R)?@'_ *_KG_T!*_-ZOTA_X+LG_BB_ /\ U_7/_HM*_-ZOY.\6/^2BJ^D? MR1_H/X ?\D9A_6?_ *7(^G/^"1/_ ">SHO\ UX7?_HJOV K\?_\ @D3_ ,GL MZ+_UX7?_ **K]@,U^P>#W_(A?^-_DC^Z MY_UX3_\ HMJWV_I6!\4/^2>ZY_UX3_\ HMJ_3\1_"EZ,_"\#_O-/_$OS/P#H MHHK^#/\ E]\_U/\ 6&/^[_\ ;OZ'[U_L^_\ )#O"'_8'M/\ T2E=?_=KD/V? M?^2&^#_^P/:?^B4KK_[M?WA@_P"!#T7Y'^469?[Y5_Q2_-B2\Q-]*_#;]M@W M1_:V^(GVSR_._MZYQLS_ *O>?+Z]]FW/OFOW(/ %?D3_ ,%<_@_<_#K]K.^U MGRW_ +-\86\=];R?P^8B+%*GU&U6/M(*_*_&;"5*F30JPVA-7]&FK_?9?,_> MOHUYA2H<25ST75O$GP_OIHX9M3D&JZ<&./.<*$F4>K M;4C8#K@.>QK\I\)+BO71K[[6]3]Z^D'E=?&<)SG15W2E&;MV M5TW\KW?DF?I%12*VZE)Q7]:'^?HUUK\\?^"Y7Q$6:#P5X3MV#R1F;5[M0?\ M4@;8HF(]"6E&3Z>]?=_Q)^(.D_"SP1J7B#7+R.QTO2X&GGFD/"@#L.I)X Y M)( Y-?%GPL^ FJ?MV?#WXL?$K7K;[+=?$"S;2_"<%P,?8;6W;=$QZX#31QDD M=T9APPKX?C>-3&X*6487^)43?I%:W?J[17J?J'A=4HY9F<.(L>OW%"27K.?N MI+NXQ;F^W*NZ/S7KO/V6O^3G?AQ_V-&F?^E45<7JVDW.@ZK0]EV)WW5\WQ#F]3#QCA,&N:O5TBNB[R?DO MQV/L^#^':&-E/,4GIY*[9V/_!/+]F[6/B_X]N/CY\2M MUUK.N.9]!M95^2UB(PLP4]!LPL8[+\W)8$?;X7']*BM+2.QMXXHU6..-0JJH MP% X [5/T(KNR;*:>78948N[;O*3WE)[M^;?X'E\3<15\YQKQ-1*,4E&$%\ M,(+X8KR2^]W?4%'%>7_M:?LV:7^U-\&]1\,ZDJ1SL//T^[V[FLKA0=D@]N2K M#NK,.]>H;N.*0GY37?BL+3Q-&5"M'FC)6:?5,\K 8ZO@L3#%X:3C.#4HM=&M MC\ /B)\/]6^%?C?5/#NMVK6>J:/<-;7$+=F'0@]U(PRD<$$$<&L6OT]_X*X? ML6_\+.\'GXC>'+/?X@T"'&I0Q#YKZT7)+8[M'R?4IN'.%%?F%7\;<9<+U.J'%.3PQD;*K'W:D>TEO\GNONW3/TC_X) ?MG_\ M"3Z,OPM\1706^TN(OH4LC?-0:_)?M/_L)^ OVJ;)IM/NR^?1_-'Z/PGXJ<09!3^KX:JIT>M M.HN:/RZI>2:7D?G9\*O^"H?Q*^ .G#2OC!X!\074=I^Z_M46;V=P0, ;E91% M(3V=63/'4\GV/1_^"Q_P=U"PCEN+K7=/D8 F&;37+)QW*;E]N&/2OJJ:SBG4 MJ\<;*1@@J,$5S^K?!_POKIS>^'=$O.2P\ZQC?!/4\J>:,+DV=86'LZ6,4XK; MGA>7WJ2O\T&,XDX8Q]1UL5EKIS>K]E5Y8OTC*$N7T3L?-OB7_@LU\(=%LO,L M_P#A(M8DQQ%;6'ED_C*R#]>U%;.8A#KVN@*(T( M^^BNH3(R#QYO'\/-?8FC?#[1/#VW[#I.G6NP!5\JW1-H'0# %:ZQ",?*JK]! M71+*U.*B_O;DU\K/S.2/$&081\^ R_FFMG5J.//B%<,)WOKO+06E &.._8U[6799A\#2]EAHV6[ZMOJVWJV^[/F,XSS&YI7^L8V; MD[67112V44K))=$E8?1117H'E%6\L8M0MI89XUFAE4H\;KN5E(P0<]:^7?CE M^P,BWDVK>"E2-7)>32I#A0>_DL>G^ZW'H<8%?53?,*,96O#SSA_!YMAW0Q';SPC=26VHVMQ9W,7#13QE6 M'X'M7-Z[J^ >:_2KQE\.]%^(-A]EUK2[34(?X1+&"R>ZMU4^X(->)>._^"<7 MA/Q+,\FEZCJVBEA@1JZW$*_0.-W_ (]7\P\0> .:QQ+KX"K&K![*6DE^:?KH M?KV4^*&"FDL;!PEW6J_S_!^I\':_J_WN:XW5O$,EI,)(Y'CDC.5=&P5/J#7V MCK__ 28U6<'[+XVLI,G_EKIK)Q^$C5C0_\ !&G4M2D4WWC^VA7=\ZP:2SDC MV)E7^7'O7GY?X5\2T9)>PL_\4?\ ,^K7'W#SA>59?^ R_*Q\7:U\AV*\^396RPJQ]3M'S-[G)-?J&2^&&95&I9G6Y8KHFV_P#) M>NI\YF7BIEF&BUE=#FGW:LO\WZ67J?%'[#O_ 1PL? 6I6?BSXJ-:ZUK$)$M MKH4>)+*S;J&E;_ELXX^4?NP<_?X(^]DB6&/:JX51@ =J>> *49 K]FRK*,+E MU'V.%C9=>[\VS\9SK/L;FN(^L8V?,^BZ)=DNGY]SRO\ :K_:,NOV:? 5CK5K MX4U?Q<]W?K9&UTY2TD0,?#8GV<>W*G^+U/1R?-LGPU#V>-P"K2N M_>]I..G16CIH?E3^W[^T=XE_;,T/P]9VGPP\::+_ &)<2S,TUG++YF]0N @ MZ8KYC_X4GXR_Z%'Q-_X*YO\ XBOWP-O&#PB>_P M M8P/]6O_?-?GN=>%:S3 M%/&8S%-S=KOE2V5EHF?L'#?C\\BP$TD]VV]6F]VS\9?V--;\ M5_LM?':Q\7W/P_\ %FK16EO-#]GBT^:-FWJ0#DJ1QGTK[-_X>U:NO_-$O'G_ M '[?_P"-5]F_9HP?]6GY"C[-&_\ I_"OL(O5V[^A M\QQ1XG9;Q#C%C\TRQ2J**C=59QT3;6BLNK/AW1?^"Q&M:I=LA^"OB@@+NQ;W M#S/U Y7R!QSUSZ5)XK_X*G:UXC\-ZA8+\%?'ON 6 MD?\ SSC_ .^12&"/_GG'^5>I_8V;N/++'-_]PXG@_P"L_#<:BJ4\H2M_T^J, M_ [_ (4GXS_Z%'Q-_P""N;_XBC_A2?C/_H4?$W_@KF_^(K]\OLT?_/-/^^11 M]FC_ .>:?]\BOSW_ (@GA>;F^LROZ+_,_8/^)GL?R\GU&-MOC?\ D?"OP[_X M*?:QX'\!:/H[_!?QW.VF6,-J9%A//\ OT__ M ,:K[-^SQ@2YM"*BL:[+_IW$_'*W$W#U6;J2RI M7;N_WU3J>8?LH_M%W/[3'@*]UJZ\*ZQX1>TOVLA:ZBI628+'&_FC*K\IWE>G M5#4G[4W[+?AS]J_X;R>']?1XVC?SK.]AQYUE+C 9<\$$$@@\$'UP1Z9%&L2? M*%7Z"E*U[DL#&MA?JN,M435I725_DM$?*1S26'Q_U_+$Z+C+F@DVW'YO5_/? MJ?C9^T'_ ,$R/BA\![VXDATB;Q5HL9)CO])C:5V7CEH1F13SSPRCGYB!FO"] M-U'5OA]XIANK:2]T?6-+F66-UW0S6TBG(/8J0:_H&>)7^\ WX5G:IX1TS7,& M]TZSNMO0S0J^.OJ#ZG\Z_)B/_ ,%II/&$OV/P;\+?$&O:DP&V'S\M]=L*2,>WIU[5 M]?#X!>"(I-R^$?#:LIR"--AR#_WS71:;X>L=&M]EG9VMJG7;%$$ _ 8KZS!< M/\14H*E5S"Z77V:;^]O\6F? YEQ=P97J.O1R9J3Z>VFHW]$MO)61\4Z1^S5\ M8OV\/$%GJ7QFN/\ A$? =G,MS!X8L3LEN\9QYAR67@X+,VX<[4CSFOM30- L MO"NAVNFZ?;PV=C8Q+!;P1)MCB10%55'0 5? YX_*E/ KZ;*\GI8*\E)SG M*W-*3NW;;R271))'PF>\28C,^6FXQITH7Y*<%:,;[OJVWUDVV^Y\;_MZ?\$N M;7]HO7+CQ=X-NK71O%4RC[9;S@BUU(J,!B5!,[KKP+K\C0OF.;34^VG(/#*8"Y'KV(]J_;7&12&-6_A'Y5\AGWACE.9XA MXMOI8_1.$_'#B#(\(L![M:DE9*=VXKLFFM.U[V6BLCX#^% M/_!2;XV>'/"=OIVO? OQ5XFU2S01R7L%I=V;3[> 6B^S. QXR00,YPHZ#J?^ M'GWQ4(_Y-G\M1X?S6G!0683LN\(-_ M-N+;^\^:Q/%>1UJLJKRBFFW?2I52^24TDO)(_+[]L_\ :(^-'[77AC3_ ^/ M@YX\\,:##,)[ZUAL;NX?4&4@H&?[.@"KR0NTC=ACG:,>D?"']N/QU\$?A[IO MA?P_^R[XTM-+TJ(11(K7>6[L['[%RS,2S'N237WR(DSG:O/?%!MXS_ O_?-< ME/A'&PQ,L:L=/VDDDWR0>BV2O'1=6E:[U/0K^(.7U64_8TVY**G57O M/>3M-.3Z)R;:6BLCY?\ V>_V[OB!\8OC!H_AO7/@;XJ\'Z;J1E\[5[MKGR;3 M9#)(N[?:HOS,BH,N.7'7H?J+O3$B5''RK_A3BV\?SYKZO+<+B*%/DQ-9U97O M=I*RTTLDD?!YOCL+BJZJ83#JA&UN6+E)-W>MY.3UT5KVT'9Q7S_^T]^VCK'[ M/?C^WT6P^&/B[QE#<6279OM,@>2%&9W3RR50C< @8\]''%>_D9--,2GLI^HK M7&4:U6GRX>IR2[V3_!Z&>5XG#4,0JF+HJK"WPN3CKWNM=#XXN/\ @J'XDN(& MC?X!_$9E<8(:SEY'_?JO@CXQ_!3Q%XM^)&JZIX8^%OCG0=%OIC-!I\FD3O\ M92W+*I5 -@;.T8X&!VK]O3%'GE5_*@VRY^ZI^HKX;/N!*N<4HTL?BG)1=U[D M4U\UKKU1^I<)^*U#ANM+$93@(P^-M0TF^C^SZIIXTFY3[4@R493L M(#HQR#@\%A_%7["?9UQ]U?RI6@7'W%_*O!R[PCHX'$0Q6%Q4XSB[IV7]6Z-' MU67X[ 4YTZBM).4M?U36Z:U3V/CM?^"I7B8'_D@OQ&_P# 67_X MU7TW\%OB+<_%KX8:3XAN]%OO#MSJ<1D?3KU2L]J0Q7:X(!SQGH.M=3Y"?\\U M_P"^12C:H]!["OTO+\'C*,^;$XAU%;;E2MYZ'XGF^9Y;B::C@L&J,D[MJ XML 9 cfx8-kxq22020earnings_htm.xml IDEA: XBRL DOCUMENT 0001420800 us-gaap:CommonStockMember 2020-08-06 2020-08-06 0001420800 cfx:TangibleEquityUnitMember 2020-08-06 2020-08-06 0001420800 2020-08-06 2020-08-06 false 0001420800 Colfax CORP 8-K 2020-08-06 DE 001-34045 54-1887631 420 National Business Parkway 5th Floor Annapolis Junction MD 20701 301 323-9000 false false false false Common Stock, par value $0.001 per share CFX NYSE 5.75% Tangible Equity Units CFXA NYSE false XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.2
COVER PAGE
Aug. 06, 2020
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Aug. 06, 2020
Entity Registrant Name Colfax CORP
Entity Incorporation, State or Country Code DE
Entity File Number 001-34045
Entity Tax Identification Number 54-1887631
Entity Address, Address Line One 420 National Business Parkway
Entity Address, Address Line Two 5th Floor
Entity Address, City or Town Annapolis Junction
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20701
City Area Code 301
Local Phone Number 323-9000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001420800
Common Stock  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol CFX
Security Exchange Name NYSE
Tangible Equity Unit  
Entity Information [Line Items]  
Title of 12(b) Security 5.75% Tangible Equity Units
Trading Symbol CFXA
Security Exchange Name NYSE
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 3 95 1 false 2 0 false 0 false false R1.htm 0001000 - Document - COVER PAGE Sheet http://www.colfaxcorp.com/role/CoverPage COVER PAGE Cover 1 false false All Reports Book All Reports cfx8-kxq22020earnings.htm cfx-20200805.xsd cfx-20200805_cal.xml cfx-20200805_def.xml cfx-20200805_lab.xml cfx-20200805_pre.xml q22020earningspressrel.htm http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cfx8-kxq22020earnings.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "calculationLink": { "local": [ "cfx-20200805_cal.xml" ] }, "definitionLink": { "local": [ "cfx-20200805_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "cfx8-kxq22020earnings.htm" ] }, "labelLink": { "local": [ "cfx-20200805_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "cfx-20200805_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "cfx-20200805.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 1, "memberStandard": 1, "nsprefix": "cfx", "nsuri": "http://www.colfaxcorp.com/20200805", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "cfx8-kxq22020earnings.htm", "contextRef": "D2020Q3Aug6", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - COVER PAGE", "role": "http://www.colfaxcorp.com/role/CoverPage", "shortName": "COVER PAGE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "cfx8-kxq22020earnings.htm", "contextRef": "D2020Q3Aug6", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "cfx_TangibleEquityUnitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible Equity Unit [Member]", "label": "Tangible Equity Unit [Member]", "terseLabel": "Tangible Equity Unit" } } }, "localname": "TangibleEquityUnitMember", "nsuri": "http://www.colfaxcorp.com/20200805", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colfaxcorp.com/role/CoverPage" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0001420800-20-000020-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001420800-20-000020-xbrl.zip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